Noven Pharmaceuticals is recalling approximately 2.7 million Daytrana (methylphenidate transdermal system) patches across multiple dosage strengths. The recall was initiated because the patches are "out of specification for mechanical peel," meaning the delivery system is defective and users may have difficulty peeling the backing off the patch to apply it. These prescription patches are used to treat ADHD and were distributed nationwide in the USA in paper cartons containing foil-sealed trays of 30 patches.
A defect in the mechanical peel process can make it difficult or impossible to remove the protective liner from the medicated patch. This delivery system failure may lead to delays in treatment or improper application of the medication.
Return product to pharmacy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.